Kestine

Medicinal product

(Invented) name

Kestine

Active substance (s)

Ebastinas

Strength

10 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R06AX22, Ebastine

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2018-10-24

Date of renewal

Documents

0771-001-002_Kestine_2021-07-09.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Ebastinas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
100350	86459	1086459	lizdinė plokštelė	N20		Receptinis	LT/L/18/0771/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2018-10-24	Registruotas